Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients--CD4+ T cells play an essential role in the rejection process.
Reinke
P
P
Clinic of Internal Medicine V-Nephrology/Transplantation, University Hospital Charité, Humboldt-University Berlin, Federal Republic of Germany.
Kern
F
F
Fietze
E
E
Döcke
W D
WD
Ewert
R
R
Emmrich
F
F
Volk
H D
HD
D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015704:CD4 Antigens / Q000276:immunology*; D004334:Drug Administration Schedule; D006084:Graft Rejection / Q000473:pathology / Q000628:therapy*; D006684:HLA-DR Antigens / Q000097:blood; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D011237:Predictive Value of Tests; D013601:T-Lymphocytes / Q000276:immunology; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D006684:HLA-DR Antigens